Lighting Science (LSCG) 10-Q 12 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 07, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	LIGHTING SCIENCE GROUP CORP
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		211,886,165
Amendment Flag	false
Entity Central Index Key	866,970
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 346,572	$ 1,609,297
Restricted cash	3,000,000	3,000,000
Accounts receivable, net	10,719,609	10,417,985
Inventories	20,046,254	22,726,162
Prepaid expenses	2,520,735	2,936,837
Other current assets	2,185,801	1,610,544
Total current assets	38,818,971	42,300,825
Property and equipment, net (includes accumulated depreciation of $11.3 million and $10.3 million as of June 30, 2015 and December 31, 2014, respectively)	1,733,073	2,650,115
Intangible assets, net	2,752,841	2,572,479
Pegasus Commitment	264,000	720,000
Debt issuance costs, less current portion	2,546,480	3,230,446
Other long-term assets	133,975	118,467
Total assets	46,249,340	51,592,332
Current liabilities:
Lines of credit	11,175,467	6,368,793
Current portion of long-term debt	69,061	58,574
Accounts payable	8,182,957	19,364,552
Provision for losses on non-cancelable purchase commitments	44,215	540,227
Accrued expenses	9,835,971	9,924,316
Total current liabilities	29,307,671	36,256,462
Note payable	28,516,029	27,813,061
Long-term debt, less current portion		35,272
Liabilities under derivative contracts	8,762,414	5,636,944
Total other liabilities	37,278,443	33,485,277
Total liabilities	66,586,114	69,741,739
Redeemable Convertible Preferred Stock	$ 491,956,776	$ 468,906,776
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $.001 par value, authorized 25,000,000 shares, 113,609 shares of Series H, 62,365 shares of Series I and 70,000 shares of Series J issued and outstanding as of June 30, 2015 and 113,609 shares of Series H, 62,365 shares of Series I and 58,475 shares of Series J issued and outstanding as of December 31, 2014	$ 0	$ 0
Common stock, $.001 par value, authorized 975,000,000 shares, 214,489,993 and 212,452,636 shares issued as of June 30, 2015 and December 31, 2014, respectively	214,490	212,453
Additional paid-in capital	310,865,676	320,175,440
Accumulated deficit	(816,373,976)	(800,328,573)
Accumulated other comprehensive loss	(3,242,240)	(3,358,003)
Treasury stock, 2,505,000 shares as of June 30, 2015 and December 31, 2014 , at cost	(3,757,500)	(3,757,500)
Total stockholders’ deficit	(512,293,550)	(487,056,183)
Total liabilities and stockholders’ deficit	46,249,340	51,592,332
Series H Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	227,220,149	227,220,149
Series I Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	124,736,627	124,736,627
Series J Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	$ 140,000,000	$ 116,950,000

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Millions	Jun. 30, 2015	Dec. 31, 2014
Accumulated Depreciation (in Dollars)	$ 11.3	$ 10.3
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	25,000,000	25,000,000
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, authorized shares	975,000,000	975,000,000
Common stock, shares issued	214,489,993	212,452,636
Treasury stock, shares	2,505,000	2,505,000
Series H Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	135,000	135,000
Redeemable Convertible Preferred Stock, shares issued	113,609	113,609
Redeemable Convertible Preferred Stock, shares outstanding	113,609	113,609
Series I Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	90,000	90,000
Redeemable Convertible Preferred Stock, shares issued	62,365	62,365
Redeemable Convertible Preferred Stock, shares outstanding	62,365	62,365
Series J Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	70,100	70,000
Redeemable Convertible Preferred Stock, shares issued	70,000	58,475
Redeemable Convertible Preferred Stock, shares outstanding	70,000	58,475

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue	$ 23,270,363	$ 19,827,864	$ 42,641,908	$ 45,753,705
Cost of goods sold (exclusive of depreciation shown below)	19,853,828	18,826,446	36,295,125	42,061,792
Gross profit	3,416,535	1,001,418	6,346,783	3,691,913
Operating expense:
Selling, distribution and administrative (includes related party expenses of $0 and $261,000 for the three months ended June 30, 2015 and 2014, respectively)	6,896,060	9,981,850	11,991,641	19,175,795
Research and development	1,052,997	1,534,582	2,234,310	3,078,606
Restructuring expense	214,066	793	297,770	205,845
Depreciation and amortization	488,071	1,000,313	994,143	2,076,323
Total operating expenses	8,651,194	12,517,538	15,517,864	24,536,569
Loss from operations	(5,234,659)	(11,516,120)	(9,171,081)	(20,844,656)
Other income (expense):
Interest income	1,163	225	1,163	636
Interest expense	(1,590,638)	(2,002,561)	(2,991,531)	(3,284,319)
Related party interest expense	(138,300)	(138,300)	(338,067)	(199,767)
Decrease in fair value of liabilities under derivative contracts	4,595,279	1,983,150	(3,505,493)	(27,496,388)
Other (expense) income, net	(77,158)	45,090	(40,394)	102,015
Total other income (expense)	2,790,346	(112,396)	(6,874,322)	(30,877,823)
Net loss	(2,444,313)	(11,628,516)	(16,045,403)	(51,722,479)
Foreign currency translation gain (loss)	70,372	(21,899)	115,763	150,705
Comprehensive loss	$ (2,373,941)	$ (11,650,415)	$ (15,929,640)	$ (51,571,774)
Parent [Member]
Other income (expense):
Basic and diluted net loss per weighted average common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Noncontrolling Interest [Member]
Other income (expense):
Basic and diluted net loss per weighted average common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Related party expenses	$ 0	$ 261,000	$ 0	$ 869,000

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Stockholders' Deficit (Unaudited) - 6 months ended Jun. 30, 2015 - USD ($)	Series J Warrants [Member]Additional Paid-in Capital [Member]	Series J Warrants [Member]	Series J Preferred Stock [Member]Additional Paid-in Capital [Member]	Series J Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
Balance at Dec. 31, 2014					$ 212,453	$ 320,175,440	$ (800,328,573)	$ (3,358,003)	$ (3,757,500)	$ (487,056,183)
Balance (in Shares) at Dec. 31, 2014					212,452,636
Issuance of restricted stock for directors' compensation					$ 2,034	127,431				129,465
Issuance of restricted stock for directors' compensation (in Shares)					2,033,905
Stock based compensation expense						2,235,720				2,235,720
Stock issued under equity compensation plans					$ 3	542				545
Stock issued under equity compensation plans (in Shares)					3,452
Issuance of Series J Warrants	$ 3,638,443	$ 3,638,443
Deemed dividends on Series J Redeemable Convertible Preferred Stock			$ (15,311,900)	$ (15,311,900)
Net loss							(16,045,403)			(16,045,403)
Foreign currency translation adjustment								115,763		115,763
Balance at Jun. 30, 2015					$ 214,490	$ 310,865,676	$ (816,373,976)	$ (3,242,240)	$ (3,757,500)	$ (512,293,550)
Balance (in Shares) at Jun. 30, 2015					214,489,993

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net loss	$ (16,045,403)	$ (51,722,479)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	994,143	2,076,323
Issuance of restricted stock for directors' compensation	129,465	199,368
Stock based compensation expense	2,235,720	2,218,544
Non-cash sales incentive	75,977	61,521
Allowance for doubtful accounts receivable	35,725	25,758
Write-down of inventory	485,102	1,094,049
Provision for losses on non-cancelable purchase commitments	(496,012)	(219,791)
Increase in fair value of derivative contracts	3,505,493	27,496,388
Amortization of debt issuance costs	733,452	1,006,589
Medley discount accretion	389,536	279,167
Interest accrued on Medley Term Loan	313,432	224,308
(Gain) loss on disposal of assets	(500)	50,199
Changes in operating assets and liabilities:
Accounts receivable	(313,140)	1,199,862
Inventories	2,194,806	(6,100,128)
Prepaid expenses	416,266	(739,662)
Other current and long-term assets	(301,502)	334,166
Accounts payable	(11,169,225)	2,153
Accrued expenses and other liabilities	(70,796)	(601,839)
Net cash used in operating activities	(16,887,461)	(23,115,504)
Cash flows from investing activities:
Purchases of property and equipment	(36,806)	(262,249)
Capitalized patents	(220,652)	(461,404)
Proceeds from sale of property and equipment	500	375,100
Net cash used in investing activities	(256,958)	(348,553)
Cash flows from financing activities:
Net proceeds (payments) from draws on lines of credit and other short-term borrowings	4,806,674	(32,718,274)
Proceeds from long-term borrowings		29,775,000
Payment of short and long-term debt	(24,785)	(2,667)
Debt issuance costs	(338,749)	(3,210,206)
Decrease in restricted cash related to line of credit		2,000,000
Proceeds from issuance of common stock under equity compensation plans	545	3,669
Fees incurred on issuance of preferred stock	(148,457)	(485,400)
Net cash provided by financing activities	15,820,228	12,837,122
Effect of exchange rate changes on cash	61,466	181,935
Net decrease in cash	(1,262,725)	(10,445,000)
Cash and cash equivalents balance at beginning of period	1,609,297	11,195,412
Cash and cash equivalents balance at end of period	346,572	750,412
Supplemental disclosures:
Interest paid during the period	2,597,495	2,562,656
Series J Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Series J Redeemable Convertible Preferred Securities	11,525,000	17,475,000
Non-cash investing and financing activities:
Deemed dividends	$ (15,311,900)	(30,332,379)
Series J Warrants [Member]
Non-cash investing and financing activities:
Reclass of Series J Warrants from liabilities to equity		37,646,300
THD Warrant [Member]
Non-cash investing and financing activities:
Reclass of THD Warrant from equity to liabilities		(74,576)
Pegasus Guaranty Warrants [Member]
Non-cash investing and financing activities:
Deemed dividends		(570,574)
Fair value of Pegasus Guaranty included in debt issuance costs		$ (2,766,000)

Note 1 - Description of Busines

Note 1 - Description of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Overview Lighting Science Group Corporation (the “Company”) was incorporated in Delaware in 1988 and designs, develops, manufactures and markets general illumination products that use light emitting diodes (“LEDs”) as their exclusive light source. The Company’s product portfolio includes LED-based retrofit lamps (replacement bulbs) used in existing light fixtures as well as purpose built LED-based luminaires (light fixtures). The Company’s lamps and luminaires are used for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. The Company assembles and manufactures products primarily through its contract manufacturers in Asia. Basis of Financial Statement Presentation The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2014 is derived from the Company’s audited financial statements. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2015. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying condensed consolidated financial statements.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates. Restricted Cash As of June 30, 2015 and December 31, 2014, as required by the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”), the Company maintained a minimum restricted cash balance of $3.0 million to collateralize the Medley Term Loan. Changes in the restricted cash balance are reflected as a financing activity in the consolidated statement of cash flows. Accounts Receivable The Company records accounts receivable at the invoiced amount when its products are shipped to customers or when specific milestone billing requirements are completed. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based on age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of June 30, 2015 and December 31, 2014, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $447 ,000 and $408,000, respectively. As of June 30, 2015 and December 31, 2014, $5.2 million and $5.4 million, respectively, of eligible accounts receivable were pledged as collateral for the three-year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with FCC, LLC d/b/a First Capital (“First Capital”). Revenue Recognition The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once those terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ‑ 09”). ASU 2014-09 seeks to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards. ASU 2014 ‑ 09 initially was effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. However, at its July 9, 2015 meeting, the FASB agreed to defer by one year the mandatory effective date of this standard, but will also provide the option to adopt it as of the original effective date. The Company is currently evaluating the impact of adopting ASU 2014 ‑ 09, but the standard is not expected to have a significant effect on its consolidated financial statements. Product Warranties The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products. Such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The warranty provision is included in accrued expenses on the condensed consolidated balance sheet. Changes in the warranty provision for the six months ended June 30, 2015 were as follows: Warranty provision as of December 31, 2014 $ 4,789,470 Additions to provision 925,361 Less warranty costs (1,743,943 ) Warranty provision as of June 30, 2015 $ 3,970,888 Fair Value Measurements The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: • Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. • Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. • Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. Fair Value of Financial Instruments Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and the note payable are carried at amounts that approximate their fair value due to the short-term maturity of these instruments and/or variable, market driven interest rates. The liabilities under derivative contracts, which represent warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period. The fair value of the warrant issued to The Home Depot, Inc. (the “THD Warrant”) in January 2011, is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until the underlying shares have been earned for each year. Such adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot, Inc. ("The Home Depot"). Once a portion of the THD Warrant vests it is recorded at its fair value at the end of each subsequent reporting period. Reclassification Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or stockholders’ deficit.

Note 3 - Liquidity and Capital

Note 3 - Liquidity and Capital Resources	6 Months Ended
	Jun. 30, 2015
Liquidity And Capital Resources [Abstract]
Liquidity And Capital Resources [Text Block]	NOTE 3. LIQUIDITY AND CAPITAL RESOURCES As shown in the condensed consolidated financial statements, the Company has experienced significant net losses as well as negative cash flows from operations since its inception, resulting in an accumulated deficit of $816.4 million and stockholders’ deficit of $512.3 million as of June 30, 2015. As of June 30, 2015, the Company had cash and cash equivalents of $347,000 and an additional $3.0 million in restricted cash subject to a cash collateral dominion agreement pursuant to the Medley Term Loan. The Company’s cash expenditures primarily relate to procurement of inventory, payment of salaries, employee benefits and other operating costs. The Company’s primary sources of liquidity have historically been borrowings from First Capital under the FCC ABL, from Medley under the Medley Term Loan and from other previous lenders, as well as sales of Common Stock and Preferred Stock (as defined below) to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings LLC (“LSGC Holdings”), LSGC Holdings II LLC (“Holdings II”), LSGC Holdings III LLC (“Holdings III”) and PCA LSG Holdings, LLC (“PCA Holdings” and collectively with Pegasus Capital, Pegasus IV, LSGC Holdings, Holdings II, Holdings III and their affiliates, “Pegasus”). Pegasus is the Company’s controlling stockholder. The Company obtained the five-year , $30.5 million Medley Term Loan from Medley on February 19, 2014, pursuant to a Term Loan Agreement (as amended from time to time the “Medley Loan Agreement”). Pursuant to the Medley Loan Agreement, the Company is required to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period and to maintain certain minimum EBITDA levels. In connection with the Medley Term Loan, the Company issued a warrant to purchase 5,000,000 shares of Common Stock to each of Medley and Medley Opportunity Fund II LP (the “Medley Warrants”). The Company also obtained a three-year revolving credit facility with a maximum line amount of $22.5 million from ACF Finco I LP (as assignee of First Capital) on April 25, 2014, pursuant to the terms of a Loan and Security Agreement (as amended from time to time, the “FCC ABL Agreement”). As of June 30, 2015, the Company had $11.2 million in borrowings outstanding under the FCC ABL Agreement and additional borrowing capacity of $2.0 million . The maximum borrowing capacity under the FCC ABL Agreement is based on a formula of eligible accounts receivable and inventory. The FCC ABL Agreement also requires the Company to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period . On January 30, 2015, the Company issued 11,525 units of its Series J securities (“Series J Securities”), at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. Each Series J Security consists of (i) one share of Series J Preferred Stock and (ii) a warrant to purchase 2,650 shares of Common Stock, at an exercise price of $0.001 per share (the “Series J Warrants”). The Series J Securities were issued pursuant to a subscription agreement entered into between the Company and Holdings III. Commencing on September 25, 2015, RW LSG Holdings LLC (“Riverwood”) and Pegasus will have the right to cause the Company to redeem their shares of Series H Convertible Preferred Stock (“Series H Preferred Stock”) and Series I Convertible Preferred Stock (“Series I Preferred Stock”), respectively. If either Riverwood or Pegasus elects to cause the Company to redeem its shares of Series H Preferred Stock or Series I Preferred Stock, all other holders of the applicable series will similarly have the right to request the redemption of their shares of Preferred Stock. In addition, commencing 10 business days after September 25, 2015, Portman Limited (“Portman”) and affiliates of Zouk Holdings Limited acting together, have a contractual right to require the Company to redeem their respective shares of Series H Preferred Stock. The Company is also required to redeem the outstanding shares of its Series J Convertible Preferred Stock (“Series J Preferred Stock” and collectively with Series H Preferred Stock and Series I Preferred Stock, the “Preferred Stock”) (a) subject to certain limited exceptions, immediately prior to the redemption of the Series H Preferred Stock, Series I Preferred Stock or any other security that ranks junior to the Series J Preferred Stock and (b) on November 14, 2019, at the election of the holders of Series J Preferred Stock (a “Special Redemption”). Holders of Preferred Stock would also have the right to require the Company to redeem such shares upon the uncured material breach of the Company’s obligations under its outstanding indebtedness or the uncured material breach of the terms of the certificates of designation governing the Preferred Stock. As of June 30, 2015, in the event the Company was required to redeem all of its outstanding shares of Preferred Stock, the Company’s maximum payment obligation would have been $492.0 million. The Company would be required to repay its outstanding obligations under the Medley Term Loan and the FCC ABL prior to any redemption of shares of Preferred Stock. As of June 30, 2015, the aggregate borrowings outstanding under these loan facilities was $39.7 million. Any redemption of the Preferred Stock would be limited to funds legally available therefor under Delaware law. The certificates of designation governing the Preferred Stock provide that if there is not a sufficient amount of cash or surplus available to pay for a redemption of Preferred Stock, then the redemption must be paid out of the remaining assets of the Company. In addition, the certificates of designation governing Preferred Stock provide that the Company is not permitted or required to redeem any shares of Preferred Stock for so long as such redemption would result in an event of default under the Company’s credit facilities. As of June 30, 2015, based solely on a review of the Company’s balance sheet, the Company did not have legally available funds under Delaware law to satisfy a redemption of its Preferred Stock. In addition, based solely on the Company’s projected balance sheet as of September 25, 2015, the Company does not believe that it will have legally available funds on or before September 25, 2015 to satisfy any such redemption. The certificate of designation governing the Series H Preferred Stock also provides that upon the occurrence of a “control event,” the Company must take any and all actions required and permitted to fix the size of its board of directors to a size that would permit Riverwood (as the primary investor of the Series H Preferred Stock) to appoint a majority of the directors to the board until the Company satisfies or otherwise cures the obligations giving rise to the control event. A control event occurs if, among other things, Riverwood exercises its optional redemption right under the certificate of designation governing the Series H Preferred Stock and the Company is unable to redeem Riverwood’s Preferred Stock. If Riverwood were to exercise its optional redemption right and a control event were to occur, Riverwood could take control of the board of directors. In addition, if the Company does not have sufficient capital available to redeem the Series J Preferred Stock in connection with a Special Redemption of the Series J Preferred Stock, the Company will be required to issue a non-interest bearing note or notes (payable 180 days after issuance) in the principal amount of the liquidation amount of any shares of Series J Preferred Stock not redeemed by the Company in connection with such Special Redemption, subject to certain limitations imposed by Delaware law governing distributions to stockholders. As discussed further in Note 14, one of the Company’s stockholders, Geveran Investments Limited (“Geveran”), filed a lawsuit against the Company and certain other defendants seeking, among other things, rescission of its $25.0 million investment in the Company. On August 28, 2014, the court presiding over the lawsuit granted Geveran’s motion for partial summary judgment with respect to its cause of action for violation of the Florida securities laws. As of June 30, 2015, the order relating to the judgment had not been entered. Although the Company cannot predict the ultimate outcome of this lawsuit, it believes the court’s summary judgment award in favor of Geveran is in error and that it has strong defenses against Geveran’s claims. In the event that the Company is not successful on appeal, it could be liable for Geveran’s $25.0 million investment, as well as interest, attorneys’ fees and court costs. After the order is entered, the Company plans to appeal and, together with the other defendants, post a bond, which would allow the Company to obtain an automatic stay of enforcement throughout the appeal process. The summary judgment order and the bond required to stay enforcement of the judgment could have an adverse effect on the Company’s liquidity and its ability to raise capital in the future. The Company continues to face challenges in its efforts to achieve positive cash flows from operations and profitability. The Company’s ability to continue to meet its obligations in the ordinary course of business is dependent upon establishing profitable operations, which may be supplemented by any additional funds raised through public or private financing or increased borrowing capacity. The Company’s supply agreement with The Home Depot, the term of which continues until July 23, 2016, does not require The Home Depot to purchase any minimum amount of products from the Company. Moreover, The Home Depot performs periodic product line reviews to assess its product offerings, which can lead to pricing pressures and/or a reallocation of its business to other suppliers. In June 2015, The Home Depot performed its most recent product line review which covered its entire private label LED lighting product offering. Although the Company has not been advised of the results of this product line review , such review could result in a material loss of revenue from sales to The Home Depot . As a result of the Company’s historical and continuing losses, the Company believes it will likely need to raise additional capital to fund its operations. There can be no assurance that sources of additional capital will be available in an amount or on terms that are acceptable to the Company, if at all. If the Company is not able to raise such additional capital, the Company may need to restructure or refinance its existing obligations, which restructuring or refinancing would require the consent and cooperation of the Company’s creditors and certain stockholders. In such event, there can be no assurance that such restructuring or refinancing could be accomplished on terms that are acceptable to the Company, if at all.

Note 4 - Detail of Certain Bala

Note 4 - Detail of Certain Balance Sheet Accounts	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block Supplement [Abstract]
Supplemental Balance Sheet Disclosures [Text Block]	NOTE 4. DETAIL OF CERTAIN BALANCE SHEET ACCOUNTS Inventories Inventories consisted primarily of finished goods as of June 30, 2015 and December 31, 2014. As of June 30, 2015 and December 31, 2014, inventories were stated net of inventory write downs of $5.1 million and $7.9 million, respectively. The Company considered a number of factors in estimating the required inventory write downs, including (i) the focus of the business on the next generation of the Company’s products, which utilize lower cost technologies, (ii) the strategic focus on core products to meet the demands of key customers and (iii) the expected demand for the Company’s current generation of products, which is approaching the end of its lifecycle upon the introduction of the next generation of products. Property and Equipment, Net Depreciation related to property and equipment was $467,000 and $985,000 for the three months ended June 30, 2015 and 2014, respectively. Depreciation related to property and equipment was $954,000 and $2.1 million for the six months ended June 30, 2015 and 2014, respectively.

Note 5 - Intangible Assets

Note 5 - Intangible Assets	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 5. INTANGIBLE ASSETS Intangible assets that have finite lives are amortized over their useful lives. The Company’s intangible assets as of June 30, 2015 and December 31, 2014 are detailed below: Cost, Less Impairment Charges Accumulated Amortization Net Book Value Estimated Remaining Useful Life (years) June 30, 2015: Technology and intellectual property $ 3,017,232 $ (264,391 ) $ 2,752,841 2.2 to 20.0 December 31, 2014: Technology and intellectual property $ 2,796,580 $ (224,101 ) $ 2,572,479 2.7 to 20.0 Total intangible asset amortization expense was $21 ,000 and $16,000 for the three months ended June 30, 2015 and 2014, respectively. Total intangible asset amortization expense was $40 ,000 and $29,000 for the six months ended June 30, 2015 and 2014, respectively.

Note 6 - Debt Issuance Costs

Note 6 - Debt Issuance Costs	6 Months Ended
	Jun. 30, 2015
Debt Issuance Costs [Abstract]
Debt Issuance Costs [Text Block]	NOTE 6. DEBT ISSUANCE COSTS The Company capitalizes its costs related to the issuance of long-term debt and amortizes these costs using the effective interest rate method over the life of the loan. Amortization of debt issuance costs and the accelerated write-off of debt issuance costs in connection with refinancing activities are recorded as a component of interest expense. As of June 30, 2015, the current portion of the debt issuance costs was $1.6 million and was included in other current assets. In connection with the FCC ABL and the Medley Term Loan, $6.0 million of debt issuance costs were capitalized, including $2.8 million related to the fair value of the guaranty of the Company’s obligations under the Medley Loan Agreement in favor of Medley (the “Pegasus Guaranty”) provided by Pegasus Capital Partners IV, L.P. and Pegasus Capital Partners V, L.P. (collectively, the “Pegasus Guarantors”). The Company amortized $400,000 and $819,000 of debt issuance costs for the three months ended June 30, 2015 and 2014, respectively. The Company amortized $733,000 and $1.0 million of debt issuance costs for the six months ended June 30, 2015 and 2014, respectively .

Note 7 - Lines of Credit and No

Note 7 - Lines of Credit and Note Payable	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 7. LINES OF CREDIT AND NOTE PAYABLE Balance Outstanding as of Facility June 30, 2015 December 31, 2014 FCC ABL, revolving line of credit $ 11,175,467 $ 6,368,793 Medley Term Loan 28,516,029 27,813,061 $ 39,691,496 $ 34,181,854 FCC ABL On April 25, 2014, the Company, entered into the FCC ABL, which provides the Company with a maximum borrowing capacity of $22.5 million, which capacity is based on a formula of eligible accounts receivable and inventory. As of June 30, 2015, the Company had additional borrowing capacity of $2.0 million. As of June 30 2015, eligible collateral included $5.2 million of accounts receivable and $8.5 million of inventory. Borrowings under the FCC ABL bear interest at a floating rate equal to one -month LIBOR plus 4.0% per annum . As of June 30, 2015, the interest rate on the FCC ABL was 4.18%. On January 30, 2015, the Company entered into an amendment to the FCC ABL, which provided additional notification and consent requirements as well as updates to certain disclosure schedules to the FCC ABL agreement . In connection with this amendment First Capital also agreed to amend the calculation of EBITDA for purposes of determining compliance with the fixed charge coverage ratio covenant for each of the six-month period ending March 31, 2015, the nine -month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015. Medley Term Loan On February 19, 2014, the Company entered into the Medley Term Loan, which provided the Company with a $30.5 million term loan facility. The Medley Term Loan bears interest at a floating rate equal to three-month LIBOR plus 12% per annum, and as of June 30, 2015, the interest rate on the Medley Term Loan was 12.28%. Additionally, $3.0 million of the Medley Term Loan was funded directly into a deposit account to which Medley has exclusive access, to further secure the loan. The outstanding principal balance and all accrued and unpaid interest on the Medley Term Loan are due and payable on February 19, 2019. The Company recognized $195,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants for both the three months ended June 30, 2015 and 2014, and $158,000 and $155,000 of accrued interest for the three months ended June 30, 2015 and 2014, respectively. The Company recognized $390,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants and $313,000 of accrued interest for the six months ended June 30, 2015, and $279,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to the commitment fees and the Medley Warrants and $224,000 of accrued interest for the period from February 19, 2014 (date of issuance) to June 30, 2014. On January 30, 2015, the Company entered into an amendment to the Medley Term Loan, which, among other things, provided additional notification and consent requirements, amends the minimum EBITDA covenant levels with respect to each of the six-month period ending March 31, 2015, the nine-month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015 and amended the definition of fixed charge coverage ratio .

Note 8 - Fair Value Measurement

Note 8 - Fair Value Measurements	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	NOTE 8. FAIR VALUE MEASUREMENTS The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2015, according to the valuation techniques the Company used to determine their fair values: Fair Value Measurement as of June 30, 2015 Quoted Price in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Level 1 Level 2 Level 3 Assets (Recurring): Pegasus Commitment $ - $ - $ 264,000 Liabilities (Recurring): Riverwood Warrants $ - $ - $ 3,357,970 September 2012 Warrants - - 264,000 Pegasus Warrant - - 1,856,000 THD Warrant - - 207,617 Medley Warrants - - 1,489,186 Pegasus Guaranty Warrants - - 1,587,641 $ - $ - $ 8,762,414 The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs , as defined above , for the six months ended June 30, 2015: Realized and unrealized Purchases, sales, Transfers in Balance gains (losses) included issuances and or out of Balance December 31, 2014 in net loss settlements Level 3 June 30, 2015 Pegasus Commitment $ 720,000 $ (456,000 ) $ - $ - $ 264,000 Riverwood Warrants (2,352,027 ) (1,005,943 ) - - (3,357,970 ) September 2012 Warrants (720,000 ) 456,000 - - (264,000 ) Pegasus Warrant (1,300,000 ) (556,000 ) - - (1,856,000 ) THD Warrant (43,928 ) (163,689 ) - - (207,617 ) Medley Warrants (577,065 ) (912,121 ) - - (1,489,186 ) Pegasus Guaranty Warrants (643,924 ) (943,717 ) - - (1,587,641 ) Total $ (4,916,944 ) $ (3,581,470 ) $ - $ - $ (8,498,414 ) The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs , as defined above , for the six months ended June 30, 2014: Realized and unrealized Purchases, sales, Transfers in Balance gains (losses) included issuances and or out of Balance December 31, 2013 in net loss settlements Level 3 June 30, 2014 Pegasus Commitment $ 1,407,335 $ 592,665 $ - $ - $ 2,000,000 Riverwood Warrants (5,002,664 ) (1,691,565 ) - - (6,694,229 ) September 2012 Warrants (1,407,335 ) (592,665 ) - - (2,000,000 ) Pegasus Warrant (2,765,047 ) (934,953 ) - - (3,700,000 ) THD Warrant - - - (74,576 ) (74,576 ) Series J Warrants - (25,140,561 ) (12,505,739 ) 37,646,300 - Medley Warrants - 139,858 (3,170,361 ) - (3,030,503 ) Pegasus Guaranty Warrants - 130,833 (3,336,574 ) - (3,205,741 ) Total $ (7,767,711 ) $ (27,496,388 ) $ (19,012,674 ) $ 37,571,724 $ (16,705,049 )

Note 9 - Stockholders' Equity

Note 9 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 9. STOCKHOLDERS' EQUITY For the three months ended June 30, 2015 and 2014, the Company recorded expense of $118 ,000 and $126,000, respectively, related to restricted stock awards to the Company’s directors. For the six months ended June 30, 2015 and 2014, the Company recorded expense of $129,000 and $199,000, respectively, related to restricted stock awards to the Company’s directors. On June 12, 2014, the Board approved the formation of a Scientific Advisory Board (the “SAB”) and issued restricted stock awards to each of the five members of the SAB as part of their compensation package. For the three and six months ended June 30, 2015, the Company recorded expense of $30 ,000 and $63,000, respectively, related to restricted stock awards to the Company’s SAB. Warrants for the Purchase of Common Stock As of June 30, 2015, the following warrants for the purchase of Common Stock were outstanding: Warrant Holder Reason for Issuance Number of Common Shares Exercise Price Expiration Date Investors in rights offering Series D Warrants 1,072,617 $ 2.95 to $2.96 March 3, 2022 through April 19, 2022 The Home Depot Purchasing agreement 7,609,183 $ 1.05 December 31, 2015 through 2018 RW LSG Management Holdings LLC Riverwood Warrants 12,664,760 Variable May 25, 2022 Certain other investors Riverwood Warrants 5,427,751 Variable May 25, 2022 Cleantech Europe II (A) LP September 2012 Warrants 3,406,041 $ 0.72 September 25, 2022 Cleantech Europe II (B) LP September 2012 Warrants 593,959 $ 0.72 September 25, 2022 Portman Limited September 2012 Warrants 4,000,000 $ 0.72 September 25, 2022 Aquillian Investments LLC Private Placement Series H 830,508 $ 1.18 September 25, 2017 Pegasus Pegasus Warrant 10,000,000 Variable May 25, 2022 Investors in Series J Follow-On Offering Series J Warrants 185,500,000 $ 0.001 January 3, 2019 through January 30, 2020 Medley Medley Warrants 10,000,000 $ 0.95 February 19, 2024 Pegasus Pegasus Guaranty Warrants 10,000,000 $ 0.50 February 19, 2024 251,104,819

Note 10 - Earnings (Loss) Per S

Note 10 - Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 10: EARNINGS (LOSS) PER SHARE In 2012, the Company determined that two classes of Common Stock had been established for financial reporting purposes only, with Common Stock attributable to controlling stockholders representing shares beneficially owned and controlled by Pegasus and the Common Stock attributable to noncontrolling stockholders representing the minority interest stockholders. For the three and six months ended June 30, 2015 and 2014, the Company computed net loss per share of noncontrolling stockholders and controlling stockholders of Common Stock using the two-class method. Net loss from operations is initially allocated based on the underlying common shares held by controlling and noncontrolling stockholders. The allocation of the net losses attributable to the Common Stock attributable to controlling stockholders is then reduced by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors, while the allocation of net losses attributable to the Common Stock attributable to noncontrolling stockholders is increased by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors The following table sets forth the computation of basic and diluted net loss per share of Common Stock: For the Three Months Ended June 30, 2015 2014 Controlling Stockholders Noncontrolling Stockholders Controlling Stockholders Noncontrolling Stockholders Basic and diluted net income per share: Net loss attributable to common stock $ (1,834,659 ) $ (609,654 ) $ (9,299,729 ) $ (2,328,787 ) Deemed dividends related to the Series J Preferred Stock attributable to all shareholders (10,238 ) (3,402 ) (106,973 ) (26,787 ) Undistributed net loss $ (1,844,897 ) $ (613,056 ) $ (9,406,702 ) $ (2,355,574 ) Basic and diluted weighted average number of common shares outstanding 298,344,752 99,139,522 234,753,151 58,785,605 Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.04 ) $ (0.04 ) For the Six Months Ended June 30, 2015 2014 Controlling Stockholders Noncontrolling Stockholders Controlling Stockholders Noncontrolling Stockholders Basic and diluted net income per share: Net loss attributable to common stock $ (12,012,096 ) $ (4,033,307 ) $ (41,848,973 ) $ (9,873,506 ) Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders - - 570,574 (570,574 ) Deemed dividends related to the Series J Preferred Stock attributable to all shareholders (11,462,973 ) (3,848,927 ) (24,542,113 ) (5,790,266 ) Undistributed net loss $ (23,475,069 ) $ (7,882,234 ) $ (65,820,512 ) $ (16,234,346 ) Basic and diluted weighted average number of common shares outstanding 293,080,898 98,407,895 203,060,746 47,908,501 Basic and diluted net loss per common share $ (0.08 ) $ (0.08 ) $ (0.32 ) $ (0.34 ) Basic earnings per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the applicable period. The Series J Warrants have an exercise price of $0.001 per share of Common Stock, and are included in the weighted average number of shares of Common Stock outstanding as there are no conditions that must be satisfied before such warrant may be exercised into the shares of Common Stock underlying such warrants. Diluted earnings per share is computed in the same manner as basic earnings per share except the number of shares is increased to assume exercise of potentially dilutive stock options, unvested restricted stock and contingently issuable shares using the treasury stock method and convertible preferred shares using the if-converted method, unless the effect of such increases would be anti-dilutive. The Company had 265.9 million and 188.7 million common stock equivalents for the three months ended June 30 , 2015 and 2014, respectively, and 260.2 million and 191.0 million common stock equivalents for the six months ended June 30 , 2015 and 2014, respectively, which were not included in the diluted net loss per common share as the common stock equivalents were anti-dilutive, as a result of being in a net loss position.

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	6 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 11: RELATED PARTY TRANSACTIONS Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Company’s largest stockholders and beneficially owned approximately 88.6% of the Common Stock as of June 30, 2015. On January 30, 2015, the Company issued an additional 11,525 units of Series J Securities, at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. The Series J Securities were issued pursuant to a subscription agreement between the Company and Holdings III, an affiliate of Pegasus Capital.

Note 12 - Restructuring Expense

Note 12 - Restructuring Expense	6 Months Ended
	Jun. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	NOTE 12. RESTRUCTURING EXPENSE The following table summarizes the Company’s restructuring expense and related charges for the periods indicated: For the Six Months Ended June 30, 2015 2014 Broad based reduction of facilities and personnel (1) $ 297,770 $ 91,568 Organization Optimization Initiative (2) - 114,277 Total $ 297,770 $ 205,845 (1) These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company’s manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015. (2) In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount and the closing of the Company’s offices in the United Kingdom and Australia. For the six months ended June 30, 2014, these expenses related to the final liquidation of the Australian entity . As of June 30, 2015, the accrued liability associated with the restructuring and other related charges consisted of the following: Workforce Excess Other Reduction Facilities Exit Costs Total Accrued liability as of December 31, 2014 $ 959,240 $ 353,269 $ 138,840 $ 1,451,349 Charges 297,770 - - 297,770 Payments (801,012 ) (77,207 ) (1,013 ) (879,232 ) Accrued liability as of June 30, 2015 $ 455,998 $ 276,062 $ 137,827 $ 869,887 The remaining accrual of $870,000 as of June 30, 2015 is expected to be paid during the year ending December 31, 2015. The restructuring and other related charges are included in the line item restructuring expense in the condensed consolidated statement of operations and comprehensive loss.

Note 13 - Concentrations of Cre

Note 13 - Concentrations of Credit Risk	6 Months Ended
	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE 13. CONCENTRATIONS OF CREDIT RISK For the three months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 93% and 72%, respectively, of the Company’s total revenue. For the six months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 87% and 75%, respectively, of total revenue. As of June 30, 2015 and December 31, 2014, The Home Depot accounts receivable balance represented 79% and 66%, respectively, of the Company’s total accounts receivable, net of allowances.

Note 14 - Commitments and Conti

Note 14 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 14. COMMITMENTS AND CONTINGENCIES The Company is subject to the possibility of loss contingencies arising in its business. Such contingencies are accounted for in accordance with ASC Topic 450, “Contingencies.” In determining loss contingencies, the Company considers the possibility of a loss and the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recorded when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. Legal Proceedings In the ordinary course of business, the Company is routinely a party to various pending and threatened legal claims and proceedings. While the ultimate outcome of these matters cannot be predicted with certainty, based on information currently available and advice of counsel, and taking into account available insurance coverage, except as noted below, the Company does not believe that the outcome of any of these claims will have a material adverse effect on its business, financial condition or results of operations. However, the results of legal proceedings cannot be predicted with certainty, and in the event of unexpected future developments the ultimate resolution of one or more of these matters could be unfavorable. Should the Company fail to prevail in any of these legal matters or should several of these legal matters be resolved against the Company in the same reporting period, the consolidated financial position or operating results could be materially adversely affected. Regardless of the outcome, any litigation may require the Company to incur significant expenses and may result in significant diversion of management’s attention. Further, during its ordinary course of business, the Company enters into obligations to defend, indemnify and/or hold harmless various customers, officers, directors, employees, and other third parties. These contractual obligations could give rise to additional litigation costs and involvement in court proceedings. Geveran Investments Limited v. Lighting Science Group Corporation, et al . (the “Geveran Case”) On June 22, 2012, Geveran Investments Limited (“Geveran”), one of the Company’s stockholders, filed a lawsuit against the Company and several other defendants in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida. On October 30, 2012, the court entered an order transferring the lawsuit to the Ninth Judicial Circuit in and for Orange County, Florida. The Geveran Case names the Company as a defendant, as well as Pegasus Capital and nine other entities affiliated with Pegasus Capital; Richard Weinberg, our former Director and former interim Chief Executive Officer and a former partner of Pegasus Capital; Gregory Kaiser, a former Chief Financial Officer; J.P. Morgan Securities, LLC (“J.P. Morgan”); and two employees of J.P. Morgan. Geveran seeks rescission of its $25.0 million investment in the Company, as well as recovery of interest, attorneys’ fees and court costs, jointly and severally against the Company, Pegasus Capital, Mr. Weinberg, Mr. Kaiser, J.P. Morgan and the two J.P. Morgan employees, for alleged violations of Florida securities laws. Geveran alternatively seeks unspecified money damages, as well as recovery of court costs, for alleged common law negligent misrepresentation against these same defendants. In August 2014, the court granted Geveran’s motion to amend their first amended complaint to assert a claim for punitive damages against the defendants. On August 28, 2014, the court issued an Order Granting Plaintiff’s Motion for Partial Summary Judgment under its First Cause of Action for Violation of the Florida Securities and Investor Protection Act (the “August 28 Order”). It is anticipated that the August 28 Order will be entered as a judgment of Court in August or September 2015. Once the August 28 Order is entered, the Company intends to appeal it. Together with the other defendants, the Company will have 30 days to post a bond during which time enforcement of the judgment would be stayed. The Company plans to have a bond posted to secure the judgment, which should result in the automatic stay of enforcement through the appeal process. While the outcome of any appeal is inherently difficult to predict, the Company believes that the trial court’s grant of summary judgment to plaintiff was in error. In the event that the summary judgment is overturned on appeal, the Company believes it has strong defenses against Geveran’s claims. The Company denies liability in connection with this matter and intends to continue to vigorously defend itself against the claims asserted by Geveran. Nonetheless, the amount of possible loss, if any, cannot be reasonably estimated at this time. The outcome, if unfavorable, would have a material adverse effect on the Company’s financial position. The Company believes that, subject to the terms and conditions of the relevant policies (including retention and policy limits), directors’ and officers’ insurance coverage will be available to cover the substantial majority of its legal fees and costs in this matter. However, given the unspecified nature of Geveran’s maximum damage claims, insurance coverage may not be available for, or such coverage may not be sufficient to fully pay, a judgment or settlement in favor of Geveran. Based upon the terms of an indemnification agreement described below, the Company has also paid, and is likely to pay in the in the future, reasonable legal expenses incurred by J.P. Morgan and its affiliates in this lawsuit in connection with the engagement of J.P. Morgan as placement agent for the private placement with Geveran. Such payments are not covered by the Company’s insurance policies. The engagement letter executed with J.P. Morgan provides that the Company will indemnify J.P. Morgan and its affiliates from liabilities relating to J.P. Morgan’s activities as placement agent, unless such activities are finally judicially determined to have resulted from J.P. Morgan’s bad faith, gross negligence or willful misconduct. GE Lighting Solutions v. Lighting Science Group Corporation , et al. The Company is also a defendant in an action brought by GE Lighting Solutions LLC (“GE Lighting”) in Federal District Court for the Northern District of Ohio in or about January 2013. GE Lighting asserts a claim of infringement by the Company, as well as five other LED manufacturers, of U.S Patent No. 6,787,999, entitled LED-Based Modular High Power LED Power Pack for Spot Module Illumination , asserts non-infringement defenses, and also asserts that the patents include terms that are indefinite and thus are invalid. On August 5, 2015, the Federal District Court granted the Company’s summary judgment motion invalidating the two GE patents at issue for indefiniteness, and dismissing GE’s patent infringement claims against the Company and the other defendants. GE will have 30 days from the date the judgment is entered in which to file a notice of appeal. If such an appeal were filed, the appellate court could reverse the judgment and remand the case back to the Federal District Court for further proceedings . Other In addition, the Company may be a party to a variety of legal actions, such as employment and employment discrimination-related suits, employee benefit claims, breach of contract actions, tort claims, shareholder suits, including securities fraud, intellectual property related litigation, and a variety of legal actions relating to its business operations. In some cases, substantial punitive damages may be sought. The Company currently has insurance coverage for certain of these potential liabilities. Other potential liabilities may not be covered by insurance, insurers may dispute coverage or the amount of insurance may not be sufficient to cover the damages awarded. In addition, certain types of damages, such as punitive damages, may not be covered by insurance and insurance coverage for all or certain forms of liability may become unavailable or prohibitively expensive in the future.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Financial Statement Presentation The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2014 is derived from the Company’s audited financial statements. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2015. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash As of June 30, 2015 and December 31, 2014, as required by the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”), the Company maintained a minimum restricted cash balance of $3.0 million to collateralize the Medley Term Loan. Changes in the restricted cash balance are reflected as a financing activity in the consolidated statement of cash flows.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable The Company records accounts receivable at the invoiced amount when its products are shipped to customers or when specific milestone billing requirements are completed. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based on age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of June 30, 2015 and December 31, 2014, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $447 ,000 and $408,000, respectively. As of June 30, 2015 and December 31, 2014, $5.2 million and $5.4 million, respectively, of eligible accounts receivable were pledged as collateral for the three-year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with FCC, LLC d/b/a First Capital (“First Capital”).
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once those terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ‑ 09”). ASU 2014-09 seeks to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards. ASU 2014 ‑ 09 initially was effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. However, at its July 9, 2015 meeting, the FASB agreed to defer by one year the mandatory effective date of this standard, but will also provide the option to adopt it as of the original effective date. The Company is currently evaluating the impact of adopting ASU 2014 ‑ 09, but the standard is not expected to have a significant effect on its consolidated financial statements.
Standard Product Warranty, Policy [Policy Text Block]	Product Warranties The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products. Such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The warranty provision is included in accrued expenses on the condensed consolidated balance sheet. Changes in the warranty provision for the six months ended June 30, 2015 were as follows: Warranty provision as of December 31, 2014 $ 4,789,470 Additions to provision 925,361 Less warranty costs (1,743,943 ) Warranty provision as of June 30, 2015 $ 3,970,888
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value Measurements The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: • Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. • Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. • Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. Fair Value of Financial Instruments Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and the note payable are carried at amounts that approximate their fair value due to the short-term maturity of these instruments and/or variable, market driven interest rates. The liabilities under derivative contracts, which represent warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period. The fair value of the warrant issued to The Home Depot, Inc. (the “THD Warrant”) in January 2011, is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until the underlying shares have been earned for each year. Such adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot, Inc. ("The Home Depot"). Once a portion of the THD Warrant vests it is recorded at its fair value at the end of each subsequent reporting period
Reclassification, Policy [Policy Text Block]	Reclassification Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or stockholders’ deficit.

Note 2 - Summary of Significa23

Note 2 - Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Schedule of Product Warranty Liability [Table Text Block]	Warranty provision as of December 31, 2014 $ 4,789,470 Additions to provision 925,361 Less warranty costs (1,743,943 ) Warranty provision as of June 30, 2015 $ 3,970,888

Note 5 - Intangible Assets (Tab

Note 5 - Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Cost, Less Impairment Charges Accumulated Amortization Net Book Value Estimated Remaining Useful Life (years) June 30, 2015: Technology and intellectual property $ 3,017,232 $ (264,391 ) $ 2,752,841 2.2 to 20.0 December 31, 2014: Technology and intellectual property $ 2,796,580 $ (224,101 ) $ 2,572,479 2.7 to 20.0

Note 7 - Lines of Credit and 25

Note 7 - Lines of Credit and Note Payable (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Balance Outstanding as of Facility June 30, 2015 December 31, 2014 FCC ABL, revolving line of credit $ 11,175,467 $ 6,368,793 Medley Term Loan 28,516,029 27,813,061 $ 39,691,496 $ 34,181,854

Note 8 - Fair Value Measureme26

Note 8 - Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value Measurement as of June 30, 2015 Quoted Price in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Level 1 Level 2 Level 3 Assets (Recurring): Pegasus Commitment $ - $ - $ 264,000 Liabilities (Recurring): Riverwood Warrants $ - $ - $ 3,357,970 September 2012 Warrants - - 264,000 Pegasus Warrant - - 1,856,000 THD Warrant - - 207,617 Medley Warrants - - 1,489,186 Pegasus Guaranty Warrants - - 1,587,641 $ - $ - $ 8,762,414
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	Realized and unrealized Purchases, sales, Transfers in Balance gains (losses) included issuances and or out of Balance December 31, 2014 in net loss settlements Level 3 June 30, 2015 Pegasus Commitment $ 720,000 $ (456,000 ) $ - $ - $ 264,000 Riverwood Warrants (2,352,027 ) (1,005,943 ) - - (3,357,970 ) September 2012 Warrants (720,000 ) 456,000 - - (264,000 ) Pegasus Warrant (1,300,000 ) (556,000 ) - - (1,856,000 ) THD Warrant (43,928 ) (163,689 ) - - (207,617 ) Medley Warrants (577,065 ) (912,121 ) - - (1,489,186 ) Pegasus Guaranty Warrants (643,924 ) (943,717 ) - - (1,587,641 ) Total $ (4,916,944 ) $ (3,581,470 ) $ - $ - $ (8,498,414 ) Realized and unrealized Purchases, sales, Transfers in Balance gains (losses) included issuances and or out of Balance December 31, 2013 in net loss settlements Level 3 June 30, 2014 Pegasus Commitment $ 1,407,335 $ 592,665 $ - $ - $ 2,000,000 Riverwood Warrants (5,002,664 ) (1,691,565 ) - - (6,694,229 ) September 2012 Warrants (1,407,335 ) (592,665 ) - - (2,000,000 ) Pegasus Warrant (2,765,047 ) (934,953 ) - - (3,700,000 ) THD Warrant - - - (74,576 ) (74,576 ) Series J Warrants - (25,140,561 ) (12,505,739 ) 37,646,300 - Medley Warrants - 139,858 (3,170,361 ) - (3,030,503 ) Pegasus Guaranty Warrants - 130,833 (3,336,574 ) - (3,205,741 ) Total $ (7,767,711 ) $ (27,496,388 ) $ (19,012,674 ) $ 37,571,724 $ (16,705,049 )

Note 9 - Stockholders' Equity (

Note 9 - Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrant Holder Reason for Issuance Number of Common Shares Exercise Price Expiration Date Investors in rights offering Series D Warrants 1,072,617 $ 2.95 to $2.96 March 3, 2022 through April 19, 2022 The Home Depot Purchasing agreement 7,609,183 $ 1.05 December 31, 2015 through 2018 RW LSG Management Holdings LLC Riverwood Warrants 12,664,760 Variable May 25, 2022 Certain other investors Riverwood Warrants 5,427,751 Variable May 25, 2022 Cleantech Europe II (A) LP September 2012 Warrants 3,406,041 $ 0.72 September 25, 2022 Cleantech Europe II (B) LP September 2012 Warrants 593,959 $ 0.72 September 25, 2022 Portman Limited September 2012 Warrants 4,000,000 $ 0.72 September 25, 2022 Aquillian Investments LLC Private Placement Series H 830,508 $ 1.18 September 25, 2017 Pegasus Pegasus Warrant 10,000,000 Variable May 25, 2022 Investors in Series J Follow-On Offering Series J Warrants 185,500,000 $ 0.001 January 3, 2019 through January 30, 2020 Medley Medley Warrants 10,000,000 $ 0.95 February 19, 2024 Pegasus Pegasus Guaranty Warrants 10,000,000 $ 0.50 February 19, 2024 251,104,819

Note 10 - Earnings (Loss) Per28

Note 10 - Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2015
Note 10 - Earnings (Loss) Per Share (Tables) [Line Items]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the Six Months Ended June 30, 2015 2014 Controlling Stockholders Noncontrolling Stockholders Controlling Stockholders Noncontrolling Stockholders Basic and diluted net income per share: Net loss attributable to common stock $ (12,012,096 ) $ (4,033,307 ) $ (41,848,973 ) $ (9,873,506 ) Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders - - 570,574 (570,574 ) Deemed dividends related to the Series J Preferred Stock attributable to all shareholders (11,462,973 ) (3,848,927 ) (24,542,113 ) (5,790,266 ) Undistributed net loss $ (23,475,069 ) $ (7,882,234 ) $ (65,820,512 ) $ (16,234,346 ) Basic and diluted weighted average number of common shares outstanding 293,080,898 98,407,895 203,060,746 47,908,501 Basic and diluted net loss per common share $ (0.08 ) $ (0.08 ) $ (0.32 ) $ (0.34 )
First Quarter [Member]
Note 10 - Earnings (Loss) Per Share (Tables) [Line Items]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the Three Months Ended June 30, 2015 2014 Controlling Stockholders Noncontrolling Stockholders Controlling Stockholders Noncontrolling Stockholders Basic and diluted net income per share: Net loss attributable to common stock $ (1,834,659 ) $ (609,654 ) $ (9,299,729 ) $ (2,328,787 ) Deemed dividends related to the Series J Preferred Stock attributable to all shareholders (10,238 ) (3,402 ) (106,973 ) (26,787 ) Undistributed net loss $ (1,844,897 ) $ (613,056 ) $ (9,406,702 ) $ (2,355,574 ) Basic and diluted weighted average number of common shares outstanding 298,344,752 99,139,522 234,753,151 58,785,605 Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.04 ) $ (0.04 )

Note 12 - Restructuring Expen29

Note 12 - Restructuring Expense (Tables)	6 Months Ended
	Jun. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs [Table Text Block]	For the Six Months Ended June 30, 2015 2014 Broad based reduction of facilities and personnel (1) $ 297,770 $ 91,568 Organization Optimization Initiative (2) - 114,277 Total $ 297,770 $ 205,845
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Workforce Excess Other Reduction Facilities Exit Costs Total Accrued liability as of December 31, 2014 $ 959,240 $ 353,269 $ 138,840 $ 1,451,349 Charges 297,770 - - 297,770 Payments (801,012 ) (77,207 ) (1,013 ) (879,232 ) Accrued liability as of June 30, 2015 $ 455,998 $ 276,062 $ 137,827 $ 869,887

Note 2 - Summary of Significa30

Note 2 - Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current	$ 3,000,000
Allowance for Doubtful Accounts Receivable	$ 447,000	$ 408,000
Products Warranty Term	5 years
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.001	$ 0.001
First Capital [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Debt Instrument, Collateral Amount	$ 5,200,000	$ 5,400,000
Medley Term Loan [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Debt Instrument, Term	5 years
Minimum [Member] | Medley Term Loan [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current	$ 3,000,000	$ 3,000,000

Note 2 - Summary of Significa31

Note 2 - Summary of Significant Accounting Policies (Details) - Summary of Warranty Provision	6 Months Ended
	Jun. 30, 2015USD ($)
Summary of Warranty Provision [Abstract]
Warranty provision	$ 3,970,888
Additions to provision	925,361
Less warranty costs	$ (1,743,943)

Note 3 - Liquidity and Capita32

Note 3 - Liquidity and Capital Resources (Details) - USD ($)	Jan. 30, 2015	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Retained Earnings (Accumulated Deficit)		$ (816,373,976)	$ (800,328,573)
Stockholders' Equity Attributable to Parent		(512,293,550)	(487,056,183)
Cash and Cash Equivalents, at Carrying Value		346,572	1,609,297	$ 750,412	$ 11,195,412
Restricted Cash and Cash Equivalents, Current		$ 3,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		251,104,819
Line of Credit, Current		$ 11,175,467	6,368,793
Preferred Stock, Redemption Amount		492,000,000
Debt, Long-term and Short-term, Combined Amount		$ 39,700,000
First Capital [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Debt Instrument, Term		3 years
Line of Credit Facility, Maximum Borrowing Capacity		$ 22,500,000
Line of Credit, Current		11,175,467	$ 6,368,793
Line of Credit Facility, Remaining Borrowing Capacity		2,000,000
Series J Preferred Stock [Member] | Holdings III [Member] | Series J Redeemable Convertible Preferred Stock [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	11,525
Share Price (in Dollars per share)	$ 1,000
Proceeds from Issuance of Redeemable Preferred Stock	$ 11,500,000
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	1
Geveran Case [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Loss Contingency, Damages Sought, Value		$ 25,000,000
Series J Warrants [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)	2,650
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.001	$ 0.001
Medley Term Loan [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Debt Instrument, Term		5 years
Line of Credit Facility, Maximum Borrowing Capacity		$ 30,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		5,000,000

Note 4 - Detail of Certain Ba33

Note 4 - Detail of Certain Balance Sheet Accounts (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Inventory Write Down	$ 5,100,000		$ 5,100,000		$ 7,900,000
Depreciation	$ 467,000	$ 985,000	$ 954,000	$ 2,100,000

Note 5 - Intangible Assets (Det

Note 5 - Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$ 21,000	$ 16,000	$ 40,000	$ 29,000

Note 5 - Intangible Assets (D35

Note 5 - Intangible Assets (Details) - Summary of Intangible Assets - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Net Book Value	$ 2,752,841	$ 2,572,479
Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, Less Impairment Charges	3,017,232	2,796,580
Accumulated Amortization	(264,391)	(224,101)
Net Book Value	$ 2,752,841	$ 2,572,479
Minimum [Member] | Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Remaining Useful Life	2 years 73 days	2 years 255 days
Maximum [Member] | Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Remaining Useful Life	20 years	20 years

Note 6 - Debt Issuance Costs (D

Note 6 - Debt Issuance Costs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Note 6 - Debt Issuance Costs (Details) [Line Items]
Amortization of Financing Costs	$ 400,000	$ 819,000	$ 733,452	$ 1,006,589
Other Current Assets [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Deferred Finance Costs, Current, Net	$ 1,600,000		1,600,000
First Capital and Medley [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Debt Issuance Cost			6,000,000
Pegasus Guaranty [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Debt Issuance Cost			$ 2,800,000

Note 7 - Lines of Credit and 37

Note 7 - Lines of Credit and Note Payable (Details) - USD ($)	1 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	Feb. 19, 2014	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current		$ 3,000,000			$ 3,000,000
Accretion of Discount					389,536	$ 279,167
Debt Instrument, Increase, Accrued Interest					(313,432)	(224,308)
First Capital [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		22,500,000			22,500,000
Line of Credit Facility, Remaining Borrowing Capacity		2,000,000			2,000,000
Debt Instrument, Collateral Amount		5,200,000			5,200,000		$ 5,400,000
Line of Credit Facility, Eligible Collateral Inventory		$ 8,500,000			$ 8,500,000
Debt Instrument, Interest Rate, Effective Percentage		4.18%			4.18%
First Capital [Member] | Accounts Receivable [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Collateral Amount		$ 5,200,000			$ 5,200,000
First Capital [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate					4.00%
Medley Term Loan [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		30,500,000			$ 30,500,000
Medley Term Loan [Member] | Medley Capital Corporation [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	12.28%
Notes Payable	$ 30,500,000
Restricted Cash and Cash Equivalents, Current	$ 3,000,000
Medley Term Loan [Member] | Medley Capital Corporation [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	12.00%
Medley Term Loan [Member] | Medley Warrants [Member] | Medley Capital Corporation [Member] | Commitment Fees [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Accretion of Discount		$ 195,000		$ 195,000	390,000	279,000
Debt Instrument, Increase, Accrued Interest			$ 155,000		$ 313,000	$ 224,000	$ 158,000

Note 7 - Lines of Credit and 38

Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
FCC ABL, revolving line of credit	$ 11,175,467	$ 6,368,793
Medley Term Loan	28,516,029	27,813,061
	39,691,496	34,181,854
First Capital [Member]
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
FCC ABL, revolving line of credit	11,175,467	6,368,793
Medley Term Loan [Member]
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
Medley Term Loan	$ 28,516,029	$ 27,813,061

Note 8 - Fair Value Measureme39

Note 8 - Fair Value Measurements (Details) - Financial Assets and Liabilities Accounted For at Fair Value on a Recurring Basis - Fair Value, Inputs, Level 3 [Member] - Fair Value, Measurements, Recurring [Member]	Jun. 30, 2015USD ($)
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	$ 8,762,414
Pegasus Commitment [Member]
Assets (Recurring):
Pegasus Commitment	264,000
Riverwood Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	3,357,970
September 2012 Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	264,000
Pegasus Warrant [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	1,856,000
THD Warrant [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	207,617
Medley Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	1,489,186
Pegasus Guaranty Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	$ 1,587,641

Note 8 - Fair Value Measureme40

Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis - Fair Value, Inputs, Level 3 [Member] - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	$ (4,916,944)	$ (7,767,711)
Realized and unrealized gains (losses) included in net loss	(3,581,470)	(27,496,388)
Purchases, sales, issuances and settlements		(19,012,674)
Transfers in or out of Level 3		37,571,724
Ending balance	(8,498,414)	(16,705,049)
Pegasus Commitment [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	720,000	1,407,335
Realized and unrealized gains (losses) included in net loss	(456,000)	592,665
Ending balance	264,000	2,000,000
Riverwood Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(2,352,027)	(5,002,664)
Realized and unrealized gains (losses) included in net loss	(1,005,943)	(1,691,565)
Ending balance	(3,357,970)	(6,694,229)
September 2012 Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(720,000)	(1,407,335)
Realized and unrealized gains (losses) included in net loss	456,000	(592,665)
Ending balance	(264,000)	(2,000,000)
Pegasus Warrant [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(1,300,000)	(2,765,047)
Realized and unrealized gains (losses) included in net loss	(556,000)	(934,953)
Ending balance	(1,856,000)	(3,700,000)
THD Warrant [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(43,928)
Realized and unrealized gains (losses) included in net loss	(163,689)
Transfers in or out of Level 3		(74,576)
Ending balance	(207,617)	(74,576)
Medley Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(577,065)
Realized and unrealized gains (losses) included in net loss	(912,121)	139,858
Purchases, sales, issuances and settlements		(3,170,361)
Ending balance	(1,489,186)	(3,030,503)
Pegasus Guaranty Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(643,924)
Realized and unrealized gains (losses) included in net loss	(943,717)	130,833
Purchases, sales, issuances and settlements		(3,336,574)
Ending balance	$ (1,587,641)	(3,205,741)
Series J Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Realized and unrealized gains (losses) included in net loss		(25,140,561)
Purchases, sales, issuances and settlements		(12,505,739)
Transfers in or out of Level 3		$ 37,646,300

Note 9 - Stockholders' Equity41

Note 9 - Stockholders' Equity (Details)	Jun. 12, 2014	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense				$ 129,465	$ 199,368
Restricted Stock [Member] | Director [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense		$ 118,000	$ 126,000
Restricted Stock [Member] | Directors [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense				129,000	$ 199,000
Restricted Stock [Member] | Scientific Advisory Board [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense		$ 30,000		$ 63,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Recipients	5

Note 9 - Stockholders' Equity42

Note 9 - Stockholders' Equity (Details) - Warrants Outstanding for Purchase of Common Stock - $ / shares	Jun. 30, 2015	Jan. 30, 2015
Class of Warrant or Right [Line Items]
Number of Common Shares	251,104,819
Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	1,072,617
Purchasing Agreement [Member] | The Home Depot [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	7,609,183
Exercise Price (in Dollars per share)	$ 1.05
Riverwood Warrants [Member] | RW LSG Management Holdings LLC [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	12,664,760
Riverwood Warrants [Member] | Certain Other Investors [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	5,427,751
September 2012 Warrants [Member] | Cleantech B [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	593,959
Exercise Price (in Dollars per share)	$ 0.72
September 2012 Warrants [Member] | Cleantech A [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	3,406,041
Exercise Price (in Dollars per share)	$ 0.72
September 2012 Warrants [Member] | Portman [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	4,000,000
Exercise Price (in Dollars per share)	$ 0.72
Private Placement Series H [Member] | Acquillian Investments LLC [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	830,508
Exercise Price (in Dollars per share)	$ 1.18
Pegasus Warrant [Member] | Pegasus Capital [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Series J Warrants [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	$ 0.001	$ 0.001
Series J Warrants [Member] | Investors in Series J Follow-on Offering [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	185,500,000
Exercise Price (in Dollars per share)	$ 0.001
Medley Warrants [Member] | Medley Capital Corporation [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Exercise Price (in Dollars per share)	$ 0.95
Pegasus Guaranty Warrants [Member] | Pegasus Capital [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Exercise Price (in Dollars per share)	$ 0.50
Minimum [Member] | Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	2.95
Maximum [Member] | Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	$ 2.96

Note 10 - Earnings (Loss) Per43

Note 10 - Earnings (Loss) Per Share (Details) - $ / shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Jan. 30, 2015
Note 10 - Earnings (Loss) Per Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	265.9	188.7	260.2	191
Series J Warrants [Member]
Note 10 - Earnings (Loss) Per Share (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.001		$ 0.001		$ 0.001

Note 10 - Earnings (Loss) Per44

Note 10 - Earnings (Loss) Per Share (Details) - Computation of Basic and Diluted Net Loss Per Share of Common Stock - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Controlling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (1,834,659)	$ (9,299,729)	$ (12,012,096)	$ (41,848,973)
Undistributed net loss	$ (1,844,897)	$ (9,406,702)	$ (23,475,069)	$ (65,820,512)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (609,654)	$ (2,328,787)	$ (4,033,307)	$ (9,873,506)
Undistributed net loss	$ (613,056)	$ (2,355,574)	$ (7,882,234)	$ (16,234,346)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Series J Preferred Stock [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (10,238)	$ (106,973)	$ (11,462,973)	$ (24,542,113)
Series J Preferred Stock [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (3,402)	$ (26,787)	$ (3,848,927)	$ (5,790,266)

Note 10 - Earnings (Loss) Per45

Note 10 - Earnings (Loss) Per Share (Details) - Computation of Basic and Diluted Net Loss Per Share of Common Stock - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Controlling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (1,834,659)	$ (9,299,729)	$ (12,012,096)	$ (41,848,973)
Undistributed net loss	$ (1,844,897)	$ (9,406,702)	$ (23,475,069)	$ (65,820,512)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (609,654)	$ (2,328,787)	$ (4,033,307)	$ (9,873,506)
Undistributed net loss	$ (613,056)	$ (2,355,574)	$ (7,882,234)	$ (16,234,346)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Series J Preferred Stock [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (10,238)	$ (106,973)	$ (11,462,973)	$ (24,542,113)
Series J Preferred Stock [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (3,402)	$ (26,787)	$ (3,848,927)	(5,790,266)
Pegasus Guaranty Warrants [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders				570,574
Pegasus Guaranty Warrants [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders				$ (570,574)

Note 11 - Related Party Trans46

Note 11 - Related Party Transactions (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended
	Jan. 30, 2015	Jun. 30, 2015
Pegasus Capital [Member]
Note 11 - Related Party Transactions (Details) [Line Items]
Ownership Percentage of Subsidiary Held in Parent		88.60%
Holdings III [Member] | Series J Redeemable Convertible Preferred Stock [Member]
Note 11 - Related Party Transactions (Details) [Line Items]
Preferred Units, Issued	11,525
Shares Issued, Price Per Share	$ 1,000
Proceeds from Other Equity	$ 11.5

Note 12 - Restructuring Expen47

Note 12 - Restructuring Expense (Details)	Jun. 30, 2015USD ($)
Note 12 - Restructuring Expense (Details) [Line Items]
Restructuring and Related Cost, Expected Cost Remaining	$ 870,000
Facility Closing [Member]
Note 12 - Restructuring Expense (Details) [Line Items]
Restructuring and Related Cost, Expected Cost	$ 200,000

Note 12 - Restructuring Expen48

Note 12 - Restructuring Expense (Details) - Restructuring Expense and Related Charges - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 214,066	$ 793	$ 297,770	$ 205,845
Facility Closing [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	[1]			$ 297,770	91,568
Organization Optimization Initiative [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	[2]				$ 114,277
[1]	These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company's manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.
[2]	In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount and the closing of the Company's offices in the United Kingdom and Australia. For the six months ended June 30, 2014, these expenses related to the final liquidation of the Australian entity.

Note 12 - Restructuring Expen49

Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		$ 869,887		$ 869,887
Charges		214,066	$ 793	297,770	$ 205,845
Payments				(879,232)
Facility Closing [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		455,998		455,998
Charges	[1]			297,770	$ 91,568
Payments				(801,012)
Excess Facilities [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		276,062		276,062
Payments				(77,207)
Other Exit Costs [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		$ 137,827		137,827
Payments				$ (1,013)
[1]	These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company's manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.

Note 13 - Concentrations of C50

Note 13 - Concentrations of Credit Risk (Details) - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Sales Revenue, Net [Member]
Note 13 - Concentrations of Credit Risk (Details) [Line Items]
Concentration Risk, Percentage	93.00%	72.00%	87.00%	75.00%
Accounts Receivable [Member]
Note 13 - Concentrations of Credit Risk (Details) [Line Items]
Concentration Risk, Percentage			79.00%		66.00%

Note 14 - Commitments and Con51

Note 14 - Commitments and Contingencies (Details) $ in Millions	6 Months Ended
	Jun. 30, 2015USD ($)
Geveran Case [Member]
Note 14 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value	$ 25

Uncategorized Items - lscg-2015

Label	Element	Value
Product Warranty Accrual	us-gaap_ProductWarrantyAccrual	$ 4,789,470
Restructuring Reserve	us-gaap_RestructuringReserve	1,451,349
Facility Closing [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	959,240
Excess Facilities [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	353,269
Other Exit Costs [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	$ 138,840